326 related articles for article (PubMed ID: 29789652)
1. Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease.
Kim Y; Jin HJ; Heo J; Ju H; Lee HY; Kim S; Lee S; Lim J; Jeong SY; Kwon J; Kim M; Choi SJ; Oh W; Yang YS; Hwang HH; Yu HY; Ryu CM; Jeon HB; Shin DM
Leukemia; 2018 Dec; 32(12):2672-2684. PubMed ID: 29789652
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
Front Immunol; 2019; 10():619. PubMed ID: 31001253
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease.
Tang B; Li X; Liu Y; Chen X; Li X; Chu Y; Zhu H; Liu W; Xu F; Zhou F; Zhang Y
Cell Physiol Biochem; 2018; 46(6):2624-2635. PubMed ID: 29763906
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ.
Kim DS; Jang IK; Lee MW; Ko YJ; Lee DH; Lee JW; Sung KW; Koo HH; Yoo KH
EBioMedicine; 2018 Feb; 28():261-273. PubMed ID: 29366627
[TBL] [Abstract][Full Text] [Related]
7. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.
Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N
Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
9. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.
Min CK; Kim BG; Park G; Cho B; Oh IH
Bone Marrow Transplant; 2007 May; 39(10):637-45. PubMed ID: 17369865
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.
Mendt M; Daher M; Basar R; Shanley M; Kumar B; Wei Inng FL; Acharya S; Shaim H; Fowlkes N; Tran JP; Gokdemir E; Uprety N; Nunez-Cortes AK; Ensley E; Mai T; Kerbauy LN; Melo-Garcia L; Lin P; Shen Y; Mohanty V; Lu J; Li S; Nandivada V; Wang J; Banerjee P; Reyes-Silva F; Liu E; Ang S; Gilbert A; Li Y; Wan X; Gu J; Zhao M; Baran N; Muniz-Feliciano L; Wilson J; Kaur I; Gagea M; Konopleva M; Marin D; Tang G; Chen K; Champlin R; Rezvani K; Shpall EJ
Front Immunol; 2021; 12():631353. PubMed ID: 34017325
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory function of whole human umbilical cord derived mesenchymal stem cells.
Zhang H; Tao Y; Liu H; Ren S; Zhang B; Chen H
Mol Immunol; 2017 Jul; 87():293-299. PubMed ID: 28531813
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model.
Gregoire-Gauthier J; Selleri S; Fontaine F; Dieng MM; Patey N; Despars G; Beauséjour CM; Haddad E
Stem Cells Dev; 2012 Jul; 21(10):1616-26. PubMed ID: 21910645
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
Lim JY; Ryu DB; Lee SE; Park G; Min CK
J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
16. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.
Nishi Y; Murakami A; Murayama Y; Tsukahara N; Okamoto S; Nakachi S; Morichika K; Tamaki K; Noguchi H; Matsushita M; Karube KN; Fukushima T; Morishima S; Kishimoto H; Masuzaki H
Transpl Immunol; 2019 Aug; 55():101205. PubMed ID: 30946889
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
19. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
20. Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation.
Tago Y; Kobayashi C; Ogura M; Wada J; Yamaguchi S; Yamaguchi T; Hayashi M; Nakaishi T; Kubo H; Ueda Y
Sci Rep; 2021 Jan; 11(1):2406. PubMed ID: 33510297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
